Your browser doesn't support javascript.
loading
Mediators between canagliflozin and renoprotection vary depending on patient characteristics: Insights from the CREDENCE trial.
Doi, Yohei; Hamano, Takayuki; Yamaguchi, Satoshi; Sakaguchi, Yusuke; Kaimori, Jun-Ya; Isaka, Yoshitaka.
Afiliación
  • Doi Y; Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Hamano T; Department of Cardiology, Pulmonology, Hypertension & Nephrology, Ehime University Graduate School of Medicine, Toon, Japan.
  • Yamaguchi S; Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Sakaguchi Y; Department of Nephrology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Kaimori JY; Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Isaka Y; Department of Nephrology, Japan Community Health Care Organization Osaka Hospital, Osaka, Japan.
Diabetes Obes Metab ; 25(10): 2944-2953, 2023 10.
Article en En | MEDLINE | ID: mdl-37385955
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Fallo Renal Crónico Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Fallo Renal Crónico Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2023 Tipo del documento: Article País de afiliación: Japón